Park JR - Search Results

1

Children's Oncology Group's 2013 blueprint for research: neuroblastoma.

Park JR, Bagatell R, London WB, Maris JM, Cohn SL, Mattay KK, Hogarty M; COG Neuroblastoma Committee. Park JR, et al. Pediatr Blood Cancer. 2013 Jun;60(6):985-93. doi: 10.1002/pbc.24433. Epub 2012 Dec 19. Pediatr Blood Cancer. 2013. PMID: 23255319 Review.

2

Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors.

Park JR, Slattery J, Gooley T, Hawkins D, Lindsley K, Villablanca JG, Matthay KK, Sanders JE. Park JR, et al. Med Pediatr Oncol. 2000 Dec;35(6):719-23. doi: 10.1002/1096-911x(20001201)35:6<719::aid-mpo52>3.0.co;2-v. Med Pediatr Oncol. 2000. PMID: 11107155 Clinical Trial.

3

Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.

Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW. Hawkins DS, et al. Cancer. 2002 Sep 15;95(6):1354-65. doi: 10.1002/cncr.10801. Cancer. 2002. PMID: 12216105 Free article.

4

Treatment of neuroblastoma in patients with neurocristopathy syndromes.

Nemecek ER, Sawin RW, Park J. Nemecek ER, et al. J Pediatr Hematol Oncol. 2003 Feb;25(2):159-62. doi: 10.1097/00043426-200302000-00015. J Pediatr Hematol Oncol. 2003. PMID: 12571470 Review.

5

Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.

Bradfield SM, Douglas JG, Hawkins DS, Sanders JE, Park JR. Bradfield SM, et al. Among authors: park jr. Cancer. 2004 Mar 15;100(6):1268-75. doi: 10.1002/cncr.20091. Cancer. 2004. PMID: 15022296 Free article.

6

Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.

Thomson B, Park JR, Felgenhauer J, Meshinchi S, Holcenberg J, Geyer JR, Avramis V, Douglas JG, Loken MR, Hawkins DS. Thomson B, et al. Among authors: park jr. Pediatr Blood Cancer. 2004 Oct;43(5):571-9. doi: 10.1002/pbc.20128. Pediatr Blood Cancer. 2004. PMID: 15382275 Clinical Trial.

7

Influenza-associated morbidity in children with cancer.

Tasian SK, Park JR, Martin ET, Englund JA. Tasian SK, et al. Among authors: park jr. Pediatr Blood Cancer. 2008 May;50(5):983-7. doi: 10.1002/pbc.21472. Pediatr Blood Cancer. 2008. PMID: 18240170 Free PMC article. Clinical Trial.

8

Neuroblastoma: biology, prognosis, and treatment.

Park JR, Eggert A, Caron H. Park JR, et al. Pediatr Clin North Am. 2008 Feb;55(1):97-120, x. doi: 10.1016/j.pcl.2007.10.014. Pediatr Clin North Am. 2008. PMID: 18242317 Review.

9

Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group.

McCune JS, Salinger DH, Vicini P, Oglesby C, Blough DK, Park JR. McCune JS, et al. Among authors: park jr. J Clin Pharmacol. 2009 Jan;49(1):88-102. doi: 10.1177/0091270008325928. Epub 2008 Oct 16. J Clin Pharmacol. 2009. PMID: 18927240 Free PMC article.

10

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.

Park JR, Villablanca JG, London WB, Gerbing RB, Haas-Kogan D, Adkins ES, Attiyeh EF, Maris JM, Seeger RC, Reynolds CP, Matthay KK; Children's Oncology Group. Park JR, et al. Pediatr Blood Cancer. 2009 Jan;52(1):44-50. doi: 10.1002/pbc.21784. Pediatr Blood Cancer. 2009. PMID: 18937318 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

481 results

Search Page

Filters